Search alternatives:
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant body (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant body (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
201
Clinicopathological factors and <i>CD44V</i> expression in primary right colon cancer.
Published 2023Subjects: -
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
Characteristics of EF1-driven single copy NR1I2, NR4A1, or RORA stably-transfected cells.
Published 2024Subjects: -
211
Expression of nuclear receptor (NR) genes using dual recombinase-mediated cassette exchange.
Published 2024Subjects: -
212
Transcripts per million (TPM) of CMV and EF1, DsRed, and Halo at 2, 4, 6, and 8 weeks.
Published 2024Subjects: -
213
-
214
-
215
-
216
-
217
-
218
-
219
-
220
Medicare clozapine data analysis.
Published 2025“…For all years, there was pronounced geographic heterogeneity (average: nine-fold) in population-corrected clozapine use. Massachusetts (2015−20: 95.4, 82.7, 76.8, 72.2, 71.2, 63.7 prescriptions per thousand enrollees) and South Dakota (2015−20: 78.0, 77.4, 78.4, 75.6, 72.0, 71.6) were the only states that prescribed significantly more than average, and none prescribed significantly less. …”